SCHEMBL5208461

SCHEMBL5208461

Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(N4CCCCC4)cc2C)CCC3)cc1

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 14/20 0.53
CCR2 P41597 3/20 0.47
CXCR3 P49682 3/20 0.47
CCR7 P32248 2/20 0.47
GFER P55789 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CXCR5 P32302 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5204042 0.84 GFER (0.42) CCR5GFEROPRM1OPRD1NPC1
SCHEMBL5210006 0.76 CCR5 (0.52) CCR5CCR2CXCR3CCR7NPC1
SCHEMBL5208454 0.76 CCR5 (0.70) CCR5CCR2CXCR3CCR7
SCHEMBL5204923 0.75 CCR5 (0.52) CCR5CCR2CXCR3CCR7NPC1
SCHEMBL5209313 0.72 CCR5 (0.74) CCR5CCR2CXCR3CCR7CXCR5
SCHEMBL15095777 0.72 CCR5 (0.74) CCR5CCR2CXCR3CCR7CXCR5
SCHEMBL3499816 0.72 CCR5 (0.53) CCR5CCR2CXCR3CCR7NPC1
SCHEMBL5210198 0.71 CCR5 (0.73) CCR5CCR2CXCR3CCR7CXCR5
SCHEMBL5209488 0.70 CCR5 (0.69) CCR5CCR2CXCR3CCR7
SCHEMBL7676932 0.70 CCR5 (0.47) CCR5CCR2CXCR3CCR7CXCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040103-B1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2007-03-14 EP disclosed
US-6413947-B1 Anilide derivative, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-02 US disclosed
US-6172061-B1 AIDS THERAPY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-01-09 US disclosed
US-6166006-A Anilide derivative, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-12-26 US disclosed
EP-1039899-A2 PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE Takeda Chemical Industries, Ltd. (JP) 2000-10-04 EP disclosed
WO-1999032100-A2 PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-07-01 WO disclosed